Skip to content
TrackPodcasts
businessApr 27, 20268:30pending

Light Science Technologies: Margins up, Injectaclad in — and 40,000 buildings still to treat

Get every episode summarized

Each time Proactive - Interviews for investors publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

About this episode

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon joined Proactive's Stephen Gunnion to discuss a transformational year, with gross margins up 11.5%, AgTech revenues rising 18%, and 14 new electronics clients added. The standout development was the full acquisition of Injectaclad, which Deacon called "transformational" — with around 40,000 UK buildings still requiring passive fire protection remediation, the opportunity stretches 10 to 15 years ahead. Regulatory improvements at the Building Safety Regulator are expected to release a backlog of approvals in the second half of 2026. With a £6.6 million fundraise strengthening the balance sheet, the company is targeting defence, healthcare and medical in electronics, and international expansion in AgTech through reseller networks. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #LightScienceTechnologies #LST #AIMStocks #AGTech #PassiveFireProtection #InjectorCloud #UKConstruction #BuildingSafety #ElectronicsManufacturing #DefenceSector #GrowthStocks #SmallCaps #InvestorUpdate #StockMarketUK #ProactiveInvestors

Know when Simon Deacon turns up

Follow Simon Deacon and once a week we email you every new episode they appeared on — including guest spots the show notes never mention, because we read the transcript.

Follow Simon Deacon

Free. Pick your own day and time.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Light Science Technologies: Margins up, Injectaclad in — and 40,000 buildings still to treat

Proactive - Interviews for investors

0:00
8:30

More episodes

More from Proactive - Interviews for investors

View all episodes →